The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target von Ferguson, Benjamin D, Liu, Ren, Rolle, Cleo E, Tan, Yi-Hung Carol, Krasnoperov, Valery, Kanteti, Rajani, Tretiakova, Maria S, Cervantes, Gustavo M, Hasina, Rifat, Hseu, Robyn D, Iafrate, A John, Karrison, Theodore, Ferguson, Mark K, Husain, Aliya N, Faoro, Leonardo, Vokes, Everett E, Gill, Parkash S, Salgia, Ravi

Volltext

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial von Luke, Jason J., Onderdonk, Benjamin E., Bhave, Sandeep R., Karrison, Theodore, Lemons, Jeffrey M., Chang, Paul, Zha, Yuanyuan, Carll, Tim, Krausz, Thomas, Huang, Lei, Martinez, Carlos, Janisch, Linda A., Hseu, Robyn D., Moroney, John W., Patel, Jyoti D., Khodarev, Nikolai N., Salama, Joseph K., Ott, Patrick A., Fleming, Gini F., Gajewski, Thomas F., Weichselbaum, Ralph R., Pitroda, Sean P., Chmura, Steven J.

Volltext

Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: Relevance to lung cancer von Kawada, Ichiro, Hasina, Rifat, Lennon, Frances E, Bindokas, Vytautas P, Usatyuk, Peter, Tan, Yi-Hung C, Krishnaswamy, Soundararajan, Arif, Qudsia, Carey, George, Hseu, Robyn D, Robinson, Matthew, Tretiakova, Maria, Brand, Toni M, Iida, Mari, Ferguson, Mark K, Wheeler, Deric L., Husain, Aliya N, Natarajan, Viswanathan, Vokes, Everett E, Singleton, Patrick A, Salgia, Ravi

Volltext

Expansion cohort of partially irradiated tumors on a phase 1 trial of pembrolizumab and ablative radiotherapy von BHave, Sandeep Ramesh, Luke, Jason J., Lemons, Jeffrey M., Janisch, Linda A., Hseu, Robyn D., Chmura, Steven J.

Volltext

Improved survival associated with local tumor response following multi-site radiotherapy and pembrolizumab: secondary analysis of a phase I trial von Luke, Jason J., Onderdonk, Benjamin E., Bhave, Sandeep R., Karrison, Theodore, Lemons, Jeffrey M., Chang, Paul, Zha, Yuanyuan, Carll, Tim, Krausz, Thomas, Huang, Lei, Martinez, Carlos, Janisch, Linda A., Hseu, Robyn D., Moroney, John W., Patel, Jyoti D., Khodarev, Nikolai N., Salama, Joseph K., Ott, Patrick A., Fleming, Gini F., Gajewski, Thomas F., Weichselbaum, Ralph R., Pitroda, Sean P., Chmura, Steven J.

Volltext

Long-term clinical outcomes and transcriptional analysis following partial and complete tumor SBRT plus pembrolizumab von Bhave, Sandeep Ramesh, Luke, Jason J., Lemons, Jeffrey, Zha, Yuanyuan, Carll, Timothy C., Krausz, Thomas, Liang, Hua, Janisch, Linda A., Hseu, Robyn D., Khodarev, Nikolai, Weichselbaum, Ralph R., Pitroda, Sean, Chmura, Steven J.

Volltext

Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors von Foster, Corey C., Fleming, Gini F., Karrison, Theodore G., Liao, Chih-Yi, Desai, Ami, Moroney, John W., Ratain, Mark J., Nanda, Rita, Polite, Blase N., Hahn, Olwen M., O'Donnell, Peter H., Vokes, Everett E., Kindler, Hedy L., Hseu, Robyn, Janisch, Linda A., Dai, Julia, Hoffman, Mark D., Weichselbaum, Ralph R., Pitroda, Sean P., Chmura, Steven J., Luke, Jason J.

Volltext

Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade von Spurr, Liam F, Martinez, Carlos A, Kang, Wenjun, Chen, Mengjie, Zha, Yuanyuan, Hseu, Robyn, Gutiontov, Stanley I, Turchan, William T, Lynch, Connor M, Pointer, Kelli B, Chang, Paul, Murgu, Septimiu, Husain, Aliya N, Cody, Brittany, Vokes, Everett E, Bestvina, Christine M, Patel, Jyoti D, Diehn, Maximilian, Gajewski, Thomas F, Weichselbaum, Ralph R, Chmura, Steven J, Pitroda, Sean P

Volltext